Encompass Health prices $500 million of 5.875% senior notes due 2034 in private offering
Encompass Health priced a private offering of $500 million of 5.875% senior notes due 2034 at 100% of principal, with closing expected on or about May 29, 2026. The company plans to use the proceeds, together with cash on hand, to redeem $400 million of its 4.500% notes due 2028 at par and to repay $100 million under its revolving credit facility, which changes the mix of its debt but the filing does not state a figure for the effect on interest expense.
Key points
- $500 million principal of 5.875% senior notes due 2034 priced at 100% of principal, announced May 14, 2026
- Expected closing on or about May 29, 2026, subject to customary conditions; interest paid semiannually on June 1 and Dec. 1, starting Dec. 1, 2026
- Proceeds plus cash on hand: $400 million to redeem 4.500% notes due 2028 (of $800 million outstanding) and $100 million to repay revolver borrowings
The filing
Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 15, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.